These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 142260)

  • 1. Nicotinic acid in the treatment of chronic hospitalized schizophrenic patients: a placebo-controlled clinical study.
    Deutsch M; Ananth JV; Ban TA
    Psychopharmacol Bull; 1977 Jul; 13(3):21-3. PubMed ID: 142260
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study.
    Ananth JV; Vacaflor L; Kekhwa G; Sterlin C; Ban TA
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):406-10. PubMed ID: 4261601
    [No Abstract]   [Full Text] [Related]  

  • 3. Nicotinic acid and nicotinamide adenine dinucleotide (NAD) therapy in schizophrenia: a review.
    Wittkopp TA; Abuzzahab FS
    Behav Neuropsychiatry; 1972; 4(7-8):6-12. PubMed ID: 4348727
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of nicotinic acid on the frequency and duration of re-hospitalization of schizophrenic patients; a controlled comparison study.
    Hoffer A
    Int J Neuropsychiatry; 1966 Jun; 2(3):234-40. PubMed ID: 4225426
    [No Abstract]   [Full Text] [Related]  

  • 5. Nicotinic acid in the treatment of schizophrenia.
    Med Lett Drugs Ther; 1973 Dec; 15(26):107-8. PubMed ID: 4271841
    [No Abstract]   [Full Text] [Related]  

  • 6. A placebo-controlled clinical study with trazodone in schizophrenic patients.
    Lehmann HE; Ban TA
    Psychopharmacol Bull; 1977 Jul; 13(3):11-2. PubMed ID: 329320
    [No Abstract]   [Full Text] [Related]  

  • 7. A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients.
    Amin MM; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):20-1. PubMed ID: 329325
    [No Abstract]   [Full Text] [Related]  

  • 8. Nicotinic acid and nicotinamide in the treatment of chronic schizophrenia.
    Vallely JF; Lovegrove TD; Hobbs GE
    Can Psychiatr Assoc J; 1971 Oct; 16(5):433-5. PubMed ID: 4261335
    [No Abstract]   [Full Text] [Related]  

  • 9. Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients.
    Ramsay RA; Ban TA; Lehmann HE; Saxena BM; Bennett J
    Can Med Assoc J; 1970 May; 102(9):939-42. PubMed ID: 4157149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperidine in chronic schizophrenic patients: a controlled double-blind study.
    Luchins DJ; Gillin JC; Wagner RL; DeLisi LE; Morihisa JM; Weinberger DR; Bigelow LB; Klein ST; Wyatt RJ
    Biol Psychiatry; 1981 Jan; 16(1):91-5. PubMed ID: 6112021
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind, placebo-controlled study of Ru-Vert in patients with vertigo.
    Pou JW; Quinn HJ
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):558-62. PubMed ID: 4965504
    [No Abstract]   [Full Text] [Related]  

  • 12. Nicotinic acid as an adjuvant in the treatment of chronic schizophrenic patients with special reference to changes in higher nervous activity.
    Saarma J; Vasar H
    Curr Ther Res Clin Exp; 1970 Nov; 12(11):729-33. PubMed ID: 4993126
    [No Abstract]   [Full Text] [Related]  

  • 13. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
    Proto C; Quadri A; Ratti S; Levi GF; Prandini BD
    G Ital Cardiol; 1978; 8(7):743-51. PubMed ID: 355033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.
    Gross HS
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459
    [No Abstract]   [Full Text] [Related]  

  • 15. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I.
    Amin MM; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):15-7. PubMed ID: 329323
    [No Abstract]   [Full Text] [Related]  

  • 16. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic thyroid releasing hormone (TRH) administered orally to chronic schizophrenic patients.
    Clark ML; Paredes A; Costiloe JP; Wood F
    Psychopharmacol Commun; 1975; 1(2):191-200. PubMed ID: 817373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, II.
    Vergara L; Amin MM; Ban TA
    Psychopharmacol Bull; 1977 Jul; 13(3):17-9. PubMed ID: 329324
    [No Abstract]   [Full Text] [Related]  

  • 19. [Active therapeutic exercises in combination with vasoactive drug in intermittent claudication (author's transl)].
    Krause D; Dittmar K
    MMW Munch Med Wochenschr; 1978 Jan; 120(2-3):69-72. PubMed ID: 414129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A standard-controlled clinical study with propericiazine in schizophrenic patients.
    Ananth JV; Ban TA
    Psychopharmacol Bull; 1977 Jul; 13(3):19-20. PubMed ID: 18754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.